Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

Similar articles for PubMed (Select 1378279)

1.

HIV-induced cysteine deficiency and T-cell dysfunction--a rationale for treatment with N-acetylcysteine.

Dröge W, Eck HP, Mihm S.

Immunol Today. 1992 Jun;13(6):211-4. Review.

PMID:
1378279
2.
3.

Plasma amino acid dysregulation after lentiviral infection.

Dröge W, Murthy KK, Stahl-Hennig C, Hartung S, Plesker R, Rouse S, Peterhans E, Kinscherf R, Fischbach T, Eck HP.

AIDS Res Hum Retroviruses. 1993 Sep;9(9):807-9.

PMID:
7903043
4.
5.

Oxygen radical release by neutrophils of HIV-infected patients.

Jarstrand C, Akerlund B.

Chem Biol Interact. 1994 Jun;91(2-3):141-6. Review.

PMID:
8194130
7.

Glutathione and immune function.

Dröge W, Breitkreutz R.

Proc Nutr Soc. 2000 Nov;59(4):595-600. Review.

PMID:
11115795
9.

Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients.

Eck HP, Gmünder H, Hartmann M, Petzoldt D, Daniel V, Dröge W.

Biol Chem Hoppe Seyler. 1989 Feb;370(2):101-8.

PMID:
2784973
10.

Effect of glutathione depletion and oral N-acetyl-cysteine treatment on CD4+ and CD8+ cells.

Kinscherf R, Fischbach T, Mihm S, Roth S, Hohenhaus-Sievert E, Weiss C, Edler L, Bärtsch P, Dröge W.

FASEB J. 1994 Apr 1;8(6):448-51.

11.

Protection against glutamate-induced cytotoxicity in C6 glial cells by thiol antioxidants.

Han D, Sen CK, Roy S, Kobayashi MS, Tritschler HJ, Packer L.

Am J Physiol. 1997 Nov;273(5 Pt 2):R1771-8.

12.

Oxidant-antioxidant status in human immunodeficiency virus infection.

Dröge W, Eck HP, Mihm S.

Methods Enzymol. 1994;233:594-601. No abstract available.

PMID:
7912408
13.
14.

Requirement for prooxidant and antioxidant states in T cell mediated immune responses.--Relevance for the pathogenetic mechanisms of AIDS?

Dröge W, Eck HP, Gmünder H, Mihm S.

Klin Wochenschr. 1991 Dec 15;69(21-23):1118-22. Review.

PMID:
1798289
16.

Effect of N-acetylcysteine(NAC) treatment on HIV-1 infection: a double-blind placebo-controlled trial.

Akerlund B, Jarstrand C, Lindeke B, Sönnerborg A, Akerblad AC, Rasool O.

Eur J Clin Pharmacol. 1996;50(6):457-61.

PMID:
8858271
17.

Effect of N-acetyl-L-cysteine on lymphocyte apoptosis, lymphocyte viability, TNF-alpha and IL-8 in HIV-infected patients undergoing anti-retroviral treatment.

Treitinger A, Spada C, Masokawa IY, Verdi JC, Van Der Sander Silveira M, Luis MC, Reis M, Ferreira SI, Abdalla DS.

Braz J Infect Dis. 2004 Oct;8(5):363-71. Epub 2005 Mar 17.

18.

N-acetylcysteine: potential for AIDS therapy.

Roederer M, Staal FJ, Ela SW, Herzenberg LA, Herzenberg LA.

Pharmacology. 1993;46(3):121-9. Review.

PMID:
8441760
19.

Plasma cysteine deficiency and decreased reduction of nitrososulfamethoxazole with HIV infection.

Naisbitt DJ, Vilar FJ, Stalford AC, Wilkins EG, Pirmohamed M, Park BK.

AIDS Res Hum Retroviruses. 2000 Dec 10;16(18):1929-38.

PMID:
11153075
20.

T4+ cell numbers are correlated with plasma glutamate and cystine levels: association of hyperglutamataemia with immunodeficiency in diseases with different aetiologies.

Eck HP, Mertens T, Rosokat H, Fätkenheuer G, Pohl C, Schrappe M, Daniel V, Näher H, Petzoldt D, Drings P, et al.

Int Immunol. 1992 Jan;4(1):7-13.

PMID:
1347232
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk